FDA approves injectable Ocrevus Zunovo for relapsing ...
WEB1 day ago · by Lori Solomon. The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection for ...
Newly identified 'compound B' holds promise as better immune ...
WEB1 day ago · Zeroing in on promising compounds. As Barakat explains, his lab starts by using machine learning and molecular modeling to narrow down potential compounds to a select few that show promise. "We do ...
Examining advances in endovascular therapy for stroke patients
WEB1 day ago · Using a Medline database search, the researchers reviewed randomized clinical trials from 2015–24 that compared endovascular therapy to medical management for large vessel occlusion stroke ...
Australia sees surge in mpox cases - Medical Xpress
WEB9 hours ago · Australia has seen a rapid rise in mpox cases in the past three months, with one health expert concerned that low vaccination rates could be driving a spike outside cities. So far this year, 737 ...
'Weekend warrior' physical activity may help protect against ...
WEB1 day ago · The investigators' analyses revealed that weekend warrior and regular physical activity patterns were each associated with substantially lower risks of over 200 diseases compared with inactivity ...
Study finds certain multiple sclerosis therapies may not slow ...
WEB2 days ago · Feedback to editors. In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain ...
Immune cells caught between worlds: Researchers explore how ...
WEB3 days ago · The team discovered that innate-like T cells mature differently in humans than in mice, and that age plays a critical role here. They found that early in life, most innate-like T cells in the ...
Skip to content